Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Ansell Launches New Hybrid Technology in GAMMEX(TM) N95 Respirator and Surgical Mask

December 3, 2012

ISELIN, New Jersey, December 3, 2012 /PRNewswire/ –

Ansell, a global leader in protection solutions today announced the latest addition to
its Active Infection Protection (AIP) portfolio, the GAMMEX N95 Respirator and Surgical
Mask, extending the AIP range beyond surgical gloves. This new mask is the first to
utilize a hybrid technology that incorporates the comfort of a standard surgical mask with
the protection of a respirator. The mask is designed to more comfortably protect
healthcare workers and patients from harmful airborne pathogens, therefore reducing the
risk of Healthcare Associated Infection (HAI).

The GAMMEX N95 Respirator and Surgical Mask filters out 95% of airborne particles down
to 0.1 micron in size, exceeding the worldwide standard for respirators of 0.3 microns set
by the National Institute for Occupational Safety and Health (NIOSH), US FDA, and Health
Canada. This allows the mask to remove many airborne particles contained in surgical smoke
and filter out 99.9% of airborne viruses and bacterial microorganisms. Its high filtration
capability, combined with TYPE II fluid resistance, makes the new GAMMEX N95 Respirator
and Surgical Mask a critical component in personal protection for Infection Control,
Isolation, ICU, ER, OR and many other areas subject to airborne pathogens and harmful
particles.

The GAMMEX N95 Respirator and Surgical Mask is designed for unrivalled comfort and
performance. Its patented Breathable Face Seal allows air to circulate through the top,
bottom and sides of the respirator, ensuring maximum breathability. The unique design
feels lighter and cooler so it can be worn comfortably for longer periods of time,
promoting compliance and further enhancing infection prevention.

“This addition to the Ansell Active Infection Protection portfolio, coupled with our
antimicrobial surgical gloves and a series of products currently in our pipeline,
demonstrates our commitment to delivering clinically relevant solutions in infection
prevention to help in the fight against healthcare associated infections,” said Anthony B.
Lopez, President and General Business Manager, Ansell Medical Solutions.

“In line with our focus on innovation, the GAMMEX N95 Respirator and Surgical Mask
provides a unique technological solution, specialized for the demands of the healthcare
environment where exposure to airborne pathogens is high,” he continued.

The GAMMEX brand offers the most innovative and technologically advanced solutions
worldwide, protecting against external aggression, allergic reactions and microbial
contamination in the perioperative environment. The GAMMEX N95 Respirator and Surgical
Mask is now available for sale in North America, with global rollout to follow in 2013.

About Ansell

Ansell is a world leader in providing superior health and safety protection solutions
that enhance human wellbeing. With operations in North America, Latin America/Caribbean,
EMEA and Asia, Ansell employs more than 10,000 people worldwide and holds leading
positions in the personal protective equipment and medical gloves market, as well as in
the sexual health and wellbeing category worldwide. Ansell operates in four main business
segments: Medical Solutions, Industrial Solutions, Specialty Markets and Sexual Wellness.

Information on Ansell and its products can be found at http://www.ansell.com

Ansell Protected | HyFlex, GAMMEX, SKYN and ACTIVARMR are trademarks owned by Ansell
Limited or one of its affiliates.

(R) and (TM) are owned by Ansell Limited or one of its affiliates.

(c) 2012 Ansell Limited. All rights reserved.

SOURCE Ansell Healthcare


Source: PR Newswire